Cargando…

Effect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis

Introduction. The aim of this study was to investigate the efficacy of herbal formula QiangGuYin (QGY) in postmenopausal women. Materials and Methods. A total of 240 participants from six clinical centers were randomly to receive alendronate 70 mg/week, QGY granules 20 g/day, and placebo. Primary en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Zhen-Yu, Zhang, Xin-Gen, Li, Chun-Wen, Liu, Kang, Liang, Bo-Cheng, Shi, Xiao-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415859/ https://www.ncbi.nlm.nih.gov/pubmed/28512501 http://dx.doi.org/10.1155/2017/6062707

Ejemplares similares

The effect of QiangGuYin on osteoporosis through the AKT/mTOR/autophagy signaling pathway mediated by CKIP-1
por: Yuan, Yifeng, et al.
Publicado: (2022)

QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels during Treatment of Primary Type I Osteoporosis
por: Li, Xuefei, et al.
Publicado: (2021)

Exploratory study of sea buckthorn enhancing QiangGuYin efficacy by inhibiting CKIP-1 and Notum activating the Wnt/β-catenin signaling pathway and analysis of active ingredients by molecular docking
por: Yuan, Yi-Feng, et al.
Publicado: (2022)

Association of Serum Periostin Level with Classical Bone Turnover Markers and Bone Mineral Density in Shanghai Chinese Postmenopausal Women with Osteoporosis
por: Li, Ran, et al.
Publicado: (2021)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

Relationship of serum GDF11 levels with bone mineral density and bone turnover markers in postmenopausal Chinese women
por: Chen, Yusi, et al.
Publicado: (2016)

Regulatory SNP of RREB1 is Associated With Bone Mineral Density in Chinese Postmenopausal Osteoporosis Patients
por: Feng, Shuo, et al.
Publicado: (2021)

Associations of IDUA and PTCH1 with Bone Mineral Density, Bone Turnover Markers, and Fractures in Chinese Elderly Patients with Osteoporosis
por: Wang, Qifei, et al.
Publicado: (2019)

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009)

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
por: Khanizadeh, Fatemeh, et al.
Publicado: (2018)

The Influence of Vitamin D Receptor Genetic Variants on Bone Mineral Density and Osteoporosis in Chinese Postmenopausal Women
por: He, Wei, et al.
Publicado: (2015)

Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women
por: Shi, Liang, et al.
Publicado: (2016)

Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women
por: Jordan, Natasha, et al.
Publicado: (2006)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle, Ovidiu Alexandru, et al.
Publicado: (2018)

Exploring the Relationship of Bone Turnover Markers and Bone Mineral Density in Community-Dwelling Postmenopausal Women
por: Wei, Xu, et al.
Publicado: (2021)

4q22.1 Contributes to Bone Mineral Density and Osteoporosis Susceptibility in Postmenopausal Women of Chinese Han Population
por: Yang, Haojie, et al.
Publicado: (2013)

The Molecular Mechanism of Traditional Chinese Medicine Prescription: Gu-tong Formula in Relieving Osteolytic Bone Destruction
por: Chang, Jinyuan, et al.
Publicado: (2022)

Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study
por: Xu, Yang, et al.
Publicado: (2022)

Role of Traditional Chinese Medicine in Bone Regeneration and Osteoporosis
por: Peng, Zhicai, et al.
Publicado: (2022)

Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women Subjected to an Aqua Fitness Training Program
por: Wochna, Krystian, et al.
Publicado: (2019)

Associations of long chain polyunsaturated fatty acids with bone mineral density and bone turnover in postmenopausal women
por: Feehan, Orlagh, et al.
Publicado: (2022)

Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis
por: Wang, Qi-Fei, et al.
Publicado: (2020)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

The effect of JuanBiQiangGu granules in combination with methotrexate on joint inflammation in rheumatoid arthritis: a randomized controlled trial
por: Ran, Lei, et al.
Publicado: (2023)

The role of bone turnover markers in screening low bone mineral density and their relationship with fracture risk in the postmenopausal period
por: Mobasseri, Majid, et al.
Publicado: (2023)

Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women: Erratum
Publicado: (2016)

Association between renal function and bone mineral density in healthy postmenopausal Chinese women
por: Li, Shuang, et al.
Publicado: (2019)

Bone Microarchitecture in Obese Postmenopausal Chinese Women: The Chinese Vertebral Osteoporosis Study (ChiVOS)
por: Qi, Wenting, et al.
Publicado: (2022)

Association of follicle‐stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition
por: Li, Lin, et al.
Publicado: (2023)

Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women
por: Berkhout, J, et al.
Publicado: (2016)

Establishing Reference Intervals for Bone Turnover Markers in the Healthy Shanghai Population and the Relationship with Bone Mineral Density in Postmenopausal Women
por: Hu, Wei-Wei, et al.
Publicado: (2013)

Perirenalfat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus
por: Wang, Wei, et al.
Publicado: (2022)

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
por: Peng, Jia, et al.
Publicado: (2021)

Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis
por: He, Jianquan, et al.
Publicado: (2020)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
por: Hu, Mingwei, et al.
Publicado: (2023)

Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2008)

Evaluation of bone mineral density and bone turnover in children on anticoagulation
por: Thom, Katharina, et al.
Publicado: (2023)

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
por: Ishikawa, Koji, et al.
Publicado: (2016)

Association of APOE Genotype with Bone Mineral Density in Men and Women: The Dong-gu and Namwon Studies
por: Kim, Sun A, et al.
Publicado: (2016)

Traditional Chinese Medicine JingYinGuBiao Formula Therapy Improves the Negative Conversion Rate of SARS-CoV2 in Patients with Mild COVID-19
por: Chen, Bowu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q7dj7o853i48gothqn1f57buif